Detalles de la búsqueda
1.
"Real world" efficacy of bulevirtide in HBV/HDV-related cirrhosis including people living with HIV: Results from the compassionate use programme at INMI Spallanzani in Rome, Italy.
HIV Med
; 24(10): 1075-1082, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37287427
2.
Third dose of SARS-CoV2 mRNA vaccination produces robust persistent cellular and humoral immune responses in liver transplant recipients.
Liver Int
; 43(5): 1120-1125, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36929682
3.
Coordinated cellular and humoral immune responses after two-dose SARS-CoV2 mRNA vaccination in liver transplant recipients.
Liver Int
; 42(1): 180-186, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34719107
4.
Daclatasvir, sofosbuvir with or without ribavirin for 24 weeks in hepatitis C genotype 3 cirrhosis: A real-life study.
Ann Hepatol
; 18(3): 434-438, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31023614
5.
Lack of reduction in serum alpha-fetoprotein during treatment with direct antiviral agents predicts hepatocellular carcinoma development in a large cohort of patients with hepatitis C virus-related cirrhosis.
J Viral Hepat
; 25(12): 1493-1500, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30112854
6.
Significance of detectable HCV RNA below the limit of quantification in patients treated with DAAs using standard and ultrasensitive protocols.
J Med Virol
; 90(7): 1264-1271, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29611880
7.
Sofosbuvir plus daclatasvir with or without ribavirin is safe and effective for post-transplant hepatitis C recurrence and severe fibrosis and cirrhosis: A prospective study.
Clin Transplant
; 32(2)2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29193356
8.
Dendritic cells activation is associated with sustained virological response to telaprevir treatment of HCV-infected patients.
Clin Immunol
; 183: 82-90, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28736275
9.
Severe drug-induced liver injury (DILI) associated with benznidazole therapy for Chagas' disease.
J Antimicrob Chemother
; 77(12): 3515-3517, 2022 11 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36173378
10.
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: a real-life strategy.
Liver Int
; 37(5): 678-683, 2017 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-27865034
11.
Daclatasvir combined with sofosbuvir or simeprevir in liver transplant recipients with severe recurrent hepatitis C infection.
Liver Transpl
; 22(4): 446-58, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26890629
12.
Rapid and preemptive evaluation of individual anti-hepatitis C virus treatment outcome capability by a short-term autologous liver tissue culture system.
New Microbiol
; 37(3): 363-7, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-25180851
13.
Determination of telaprevir in plasma of HCV-infected patients by HPLC-UV.
IUBMB Life
; 65(9): 800-5, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-23893913
14.
Torquetenovirus Loads in Peripheral Blood Predict Both the Humoral and Cell-Mediated Responses to SARS-CoV-2 Elicited by the mRNA Vaccine in Liver Transplant Recipients.
Vaccines (Basel)
; 11(11)2023 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38005988
15.
High prevalence of asymptomatic SARS-CoV-2 infection in a cohort of liver transplant recipients in central Italy.
J Liver Transpl
; 5: 100064, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-38620857
16.
Late Relapse and Reinfection in HCV Patients Treated with Direct-Acting Antiviral (DAA) Drugs.
Viruses
; 13(6)2021 06 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34208646
17.
Increased plasma concentration of ribavirin as a result of renal dysfunction in hepatitis C virus patients treated with telaprevir.
Hepatology
; 60(3): 1109-10, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24375509
18.
The impact of the coronavirus disease 2019 pandemic on a central Italy transplant center.
Medicine (Baltimore)
; 99(41): e22174, 2020 Oct 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33031261
19.
Daclatasvir-based regimens in HCV cirrhosis: experience from the Italian early access program.
Sci Rep
; 9(1): 585, 2019 01 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-30679515
20.
Characterization of Naturally Occurring NS5A and NS5B Polymorphisms in Patients Infected with HCV Genotype 3a Treated with Direct-Acting Antiviral Agents.
Viruses
; 9(8)2017 08 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28783119